All Stories

  1. Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis

    Article • Clinical and Experimental Gastroenterology, January 2014, Taylor & Francis

    Dr Shitalkumar P Zambad, Ram Gupta

  2. TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats

    Article • Diabetes Metabolic Syndrome and Obesity, January 2011, Taylor & Francis

    Dr Shitalkumar P Zambad, Ram Gupta